Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis

NCT03736161 is registered in ClinicalTrials.gov with Globe Pharmaceuticals Limited as lead sponsor.

NCT NCT03736161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis
Lead sponsor
Globe Pharmaceuticals Limited
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2017
Completion date
September 28, 2019
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis